Yoshitake Hayashi Selected Research

rad9 protein

11/2008	DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.
3/2006	His239Arg SNP of HRAD9 is associated with lung adenocarcinoma.
1/2005	Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshitake Hayashi Research Topics

Disease

24	Infections 01/2020 - 01/2004
18	Neoplasms (Cancer) 12/2020 - 04/2002
16	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 01/2002
14	Chronic Hepatitis C 01/2017 - 01/2002
10	Chronic Hepatitis B 11/2019 - 05/2004
10	Chronic Hepatitis (Chronic Active Hepatitis) 10/2015 - 01/2002
9	Hepatitis B 10/2017 - 07/2005
8	Fibrosis (Cirrhosis) 09/2020 - 01/2004
8	Liver Diseases (Liver Disease) 06/2019 - 01/2003
6	Adenocarcinoma of Lung 10/2016 - 03/2006
6	Hepatitis 09/2016 - 03/2004
5	Insulin Resistance 01/2020 - 09/2003
5	Atherosclerosis 05/2009 - 01/2002
4	Virus Diseases (Viral Diseases) 01/2020 - 04/2013
4	Disease Progression 10/2016 - 07/2007
4	Carcinoma (Carcinomatosis) 09/2016 - 11/2003
3	Coinfection 04/2013 - 01/2009
2	Primary Myelofibrosis (Myelosclerosis) 09/2020 - 07/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2020 - 01/2010
2	Rheumatoid Arthritis 01/2020 - 05/2006
2	Adenocarcinoma 12/2019 - 10/2016
2	Hepatitis A (Hepatitis, Infectious) 10/2014 - 04/2013
2	Carcinogenesis 07/2014 - 11/2003
2	Non-alcoholic Fatty Liver Disease 07/2012 - 03/2007
2	Inflammation (Inflammations) 07/2012 - 03/2004
2	Lung Neoplasms (Lung Cancer) 05/2011 - 11/2008
2	Body Weight (Weight, Body) 04/2010 - 01/2009
2	Pancreatitis 11/2009 - 01/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Epstein-Barr Virus Infections 01/2020
1	Lymphadenopathy 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2019
1	Lymphoma (Lymphomas) 07/2019
1	Thrombosis (Thrombus) 05/2019
1	Pathologic Complete Response 01/2017

Drug/Important Bio-Agent (IBA)

18	InterferonsIBA 11/2019 - 01/2002
14	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2008
12	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 10/2006
11	Proteins (Proteins, Gene)FDA Link 12/2020 - 04/2002
7	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2003
7	RNA (Ribonucleic Acid)IBA 01/2013 - 01/2002
6	Antiviral Agents (Antivirals)IBA 05/2019 - 08/2005
5	Hepatitis B e AntigensIBA 07/2013 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2013
4	AntigensIBA 01/2018 - 01/2008
4	Pharmaceutical PreparationsIBA 06/2016 - 11/2009
4	Surface Antigens (Surface Antigen)IBA 10/2015 - 07/2005
3	Alanine Transaminase (SGPT)IBA 04/2013 - 07/2005
3	Biological ProductsIBA 05/2011 - 04/2002
3	rad9 proteinIBA 11/2008 - 01/2005
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2007 - 01/2002
3	Interferon-alpha (Interferon Alfa)IBA 08/2005 - 01/2004
3	EnzymesIBA 07/2003 - 01/2002
2	CollagenIBA 12/2020 - 10/2007
2	VaccinesIBA 01/2020 - 01/2016
2	Insulin (Novolin)FDA Link 01/2020 - 09/2003
2	Immunoglobulins (Immunoglobulin)IBA 11/2017 - 05/2010
2	HLA-DP Antigens (HLA-DP)IBA 10/2017 - 01/2016
2	SofosbuvirIBA 01/2017 - 01/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 01/2005
2	gadolinium ethoxybenzyl DTPA FDA Link 10/2015 - 07/2009
2	Tumor Biomarkers (Tumor Markers)IBA 10/2015 - 11/2003
2	telaprevirIBA 01/2015 - 06/2014
2	Immunoglobulin M (IgM)IBA 10/2014 - 04/2013
2	Ethanol (Ethyl Alcohol)IBA 06/2009 - 04/2008
2	oxidized low density lipoproteinIBA 05/2009 - 11/2002
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2008 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 04/2003
2	Triglycerides (Triacylglycerol)IBA 03/2007 - 09/2003
2	LipidsIBA 03/2007 - 09/2003
2	AntioxidantsIBA 05/2006 - 01/2002
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2004 - 11/2003
2	nucleotide pyrophosphataseIBA 04/2004 - 11/2003
2	NAD (NADH)IBA 10/2003 - 11/2002
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2003 - 11/2002
1	Complementary DNA (cDNA)IBA 12/2020
1	Reticulin (Reticular Fiber)IBA 09/2020
1	SteroidsIBA 09/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2020
1	efavirenz (Sustiva)FDA Link 01/2020
1	Leukotriene B4IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	UracilIBA 12/2019
1	TegafurIBA 12/2019
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 07/2019
1	EpitopesIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2017
1	adefovirIBA 09/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017

Therapy/Procedure

27	Therapeutics 01/2018 - 01/2002
3	Renal Dialysis (Hemodialysis) 09/2016 - 08/2013
2	Aftercare (After-Treatment) 01/2017 - 01/2005
2	Radiotherapy 11/2010 - 01/2006
1	Drug Therapy (Chemotherapy) 12/2019
1	Adjuvant Chemotherapy 12/2019